EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Rpf‐Toxo: A Preliminary Computationally Designed Dense Granule Antigen‐Based Multi‐Epitope Vaccine Against Toxoplasma gondii

Mohamad Hosein Safari iD, Seyyed Amir Hosseini, Shadan Ghiabi iD, Shamim Ghiabi, Davood Siamian iD, Hamidreza Majidiani iD, Hamid Irannejad iD, Ali Asghari iD

Veterinary Medicine and Science · 2026

DOI: 10.1002/vms3.71189 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Veterinary Medicine and Science, 2026. Verfasst von Mohamad Hosein Safari und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran. Hauptthemen laut MEDLINE: Toxoplasma, Antigens, Protozoan, Protozoan Vaccines, Toxoplasmosis, Animal. Die Arbeit nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Toxoplasma gondii is a protozoan parasite of medical and veterinary importance causing abortion. While current therapies are limited to address the chronic phase of infection, effective prophylactic vaccines are warranted.

Objectives

In this study, we applied a rational vaccine design approach centred around immunodominant dense granule antigens (GRAs).

Methods

In silico epitope mapping was performed on six GRAs (GRA15, GRA60, GRA76, GRA83, GRA‐α and GRA‐β). Using web servers, B‐cell, cytotoxic T‐lymphocyte and helper T‐lymphocyte epitopes were predicted and then filtered for antigenicity, solubility and allergenicity. We designed four vaccine constructs by fusing predicted epitopes with specific linkers and adjuvants (RS‐09, RpfE/50S ribosomal protein of Mycobacterium tuberculosis , and human interferon gamma [IFN‐γ]). Constructs were subjected to rigorous evaluation, which included physicochemical evaluation, 3D structural prediction and refinement, toll‐like receptor‐4 (TLR‐4) docking, immune simulation and codon adaptation.

Results

All candidates exhibited high antigenicity (VaxiJen scores > 0.9) and solubility (> 0.6). Rpf‐Toxo emerged optimal, with non‐allergenic, antigenic (0.9148), soluble (0.658), stable (instability index: 35.41) and hydrophilic (grand average of hydropathicity: −0.641) properties. Docking revealed strong TLR‐4 binding activity (affinity: −20.6 kcal/mol; K d : 7.3e‐16 M) and immune simulation predicted robust responses, including antibody titers > 170,000, Th1‐skewed IFN‐γ (380,000 ng/mL) and memory cell activation; however, these in silico predictions need experimental validation. Codon optimization enhanced expression (CAI: 1.00; GC: 65.63%), and in silico cloning indicated compatibility with pET28a(+).

Conclusion

These computational predictions require future experimental validation through in vitro and in vivo studies to confirm safety and protective efficacy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ToxoplasmaAntigens, ProtozoanProtozoan VaccinesToxoplasmosis, AnimalEpitopesProtozoan ProteinsAnimalsProtein Subunit VaccinesImmunoinformaticsComputer SimulationEpitope Mapping

Stichwörter der Autor:innen

GRAsToxoplasma gondiiantigenscomputer simulationmulti‐epitopevaccines

Substanzen

Antigens, ProtozoanProtozoan VaccinesProtein Subunit VaccinesEpitopesProtozoan Proteins

Autor:innen und Institutionen

  • Department of Internal Medicine, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran.
  • Faculty of Veterinary Medicine, Science and Research Branch, Islamic Azad University, Tehran, Iran.
  • Department of Medical Chemistry, Faculty of Pharmacy, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
  • Department of Biology, Faculty of Basic Science, Islamic Azad University, Tonekabon Branch, Iran.
  • Department of Basic Medical Sciences, Faculty of Medicine, Neyshabur University of Medical Sciences, Neyshabur, Iran.
  • Department of Medicinal Chemistry, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.

ORCID-Profile: Mohamad Hosein Safari, Shadan Ghiabi, Davood Siamian, Hamidreza Majidiani, Hamid Irannejad, Ali Asghari

Zitieren

APA

Safari, M. H., Hosseini, S. A., Ghiabi, S., Ghiabi, S., Siamian, D., Majidiani, H., Irannejad, H., & Asghari, A. (2026). Rpf‐Toxo: A Preliminary Computationally Designed Dense Granule Antigen‐Based Multi‐Epitope Vaccine Against Toxoplasma gondii. Veterinary Medicine and Science. https://doi.org/10.1002/vms3.71189

Vancouver

Safari MH, Hosseini SA, Ghiabi S, Ghiabi S, Siamian D, Majidiani H, et al. Rpf‐Toxo: A Preliminary Computationally Designed Dense Granule Antigen‐Based Multi‐Epitope Vaccine Against Toxoplasma gondii. Veterinary Medicine and Science. 2026. doi:10.1002/vms3.71189

BibTeX
@article{Safari2026,
  author = {Safari, Mohamad Hosein and Hosseini, Seyyed Amir and Ghiabi, Shadan and Ghiabi, Shamim and Siamian, Davood and Majidiani, Hamidreza and Irannejad, Hamid and Asghari, Ali},
  title = {Rpf‐Toxo: A Preliminary Computationally Designed Dense Granule Antigen‐Based Multi‐Epitope Vaccine Against Toxoplasma gondii},
  journal = {Veterinary Medicine and Science},
  year = {2026},
  doi = {10.1002/vms3.71189}
}
Kostenlos starten →